Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM511554 (US11059794, Example 6.14 | tert-butyl 4-(2-fluoro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM442736 (4-[5-[2-cyclopropyl-6-(oxan-4- | US10647719, Examp...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM477064 (US10882857, Example 4.02 | US11673888, Example 4.0...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2NV9P52 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511524 (US11059794, Example 4.00) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511578 (US11059794, Example 6.38 | tert-butyl 4-[2-(5- sul...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM442712 (US10647719, Example 1.23 | [6-chloro-3-(2,2-) | UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511585 (US11059794, Example 6.45 | tert-butyl 4-[2-[(5-sul...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM442699 (3-fluoro-4-(5-(2-((5-methyl-2H- | BDBM442731 | US1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM442729 (3-fluoro-4-[2-[3-[2-[(4-methyltriazol- | US1064771...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM477058 (US10882857, Example 2.06 | US11673888, Example 2.0...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2NV9P52 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM467326 (US10800786, Example 2.01) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10800786 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BZT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511558 (US11059794, Example 6.18 | tert-butyl 4-[2-(2-fluo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM442719 (US10647719, Example 2.01 | [4-(trifluoromethoxy)ph...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM442717 (BDBM442732 | US10647719, Example 1.28 | [3-(2,2-di...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511541 (US11059794, Example 6.03 | tert-butyl 4-[2-(2,3-di...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511538 (US11059794, Example 6.00) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511530 (4-(piperidin-4- ylmethyl)benzenesulfonamide hydroc...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511551 (US11059794, Example 6.13 | tert-butyl 4-(2-fluoro-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM477062 (US10882857, Example 4 | US11673888, Example 4 | [3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2NV9P52 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511579 (US11059794, Example 6.39 | tert-butyl 4-(3-fluoro-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM467343 (US10800786, Example 2.15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10800786 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BZT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM467346 (US10800786, Example 5.00) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffman-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10800786 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BZT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM442707 (US10647719, Example 1.18 | [6-chloro-3-(2,2-) | UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511567 (US11059794, Example 6.27 | tert-butyl 4-(2,3-diflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (Homo sapiens (Human)) | BDBM477058 (US10882857, Example 2.06 | US11673888, Example 2.0...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Assay buffer (50 mM Tris-HCl, 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.01% Triton-X-100, pH 8.0;ATX solution: ATX (human His-tagged) stock so... | US Patent US10882857 (2021) BindingDB Entry DOI: 10.7270/Q2SQ93GX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (Homo sapiens (Human)) | BDBM477062 (US10882857, Example 4 | US11673888, Example 4 | [3...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Assay buffer (50 mM Tris-HCl, 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.01% Triton-X-100, pH 8.0;ATX solution: ATX (human His-tagged) stock so... | US Patent US10882857 (2021) BindingDB Entry DOI: 10.7270/Q2SQ93GX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (Homo sapiens (Human)) | BDBM477064 (US10882857, Example 4.02 | US11673888, Example 4.0...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Assay buffer (50 mM Tris-HCl, 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.01% Triton-X-100, pH 8.0;ATX solution: ATX (human His-tagged) stock so... | US Patent US10882857 (2021) BindingDB Entry DOI: 10.7270/Q2SQ93GX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511581 (US11059794, Example 6.41 | tert-butyl 4-(2-fluoro-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM442737 (4-[5-[2-cyclopyropyl-6-[(1- | US10647719, Example ...) | UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM442717 (BDBM442732 | US10647719, Example 1.28 | [3-(2,2-di...) | UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM511550 (US11059794, Example 6.12 | tert-butyl 3-(2-fluoro-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM511520 (US11059794, Example 2.00 | US11059794, Example 2.0...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM511540 (US11059794, Example 6.02 | tert-butyl 4-(2,3-diflu...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM442718 (US10647719, Example 2.00) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM442725 (4-[2-[2-[4-cyano-2-[(5-methyl- | US10647719, Examp...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM464378 (US10787459, Example 1.00 | US10787459, Example 1.0...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Assay working solutions were made as follows:Assay buffer (50 mM Tris-HCl, 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.01% Triton-X-100, pH 8.0;... | US Patent US10787459 (2020) BindingDB Entry DOI: 10.7270/Q27084GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carbonic anhydrase 2 (Homo sapiens (Human)) | BDBM442738 (US10647719, Example 2.04 | [5-chloro-3-[(5-methylt...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511525 (2-fluoro-4-sulfamoylbenzoic acid (CAS-RN 714968-42...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511523 (US11059794, Example 3.00) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (Homo sapiens (Human)) | BDBM477060 (US10882857, Example 3.01 | US11673888, Example 3.0...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Assay buffer (50 mM Tris-HCl, 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.01% Triton-X-100, pH 8.0;ATX solution: ATX (human His-tagged) stock so... | US Patent US10882857 (2021) BindingDB Entry DOI: 10.7270/Q2SQ93GX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (Homo sapiens (Human)) | BDBM477049 (US10882857, Example 1.01 | US11673888, Example 1.0...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Assay buffer (50 mM Tris-HCl, 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.01% Triton-X-100, pH 8.0;ATX solution: ATX (human His-tagged) stock so... | US Patent US10882857 (2021) BindingDB Entry DOI: 10.7270/Q2SQ93GX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (Homo sapiens (Human)) | BDBM477042 (US10882857, Example 1 | US11673888, Example 1 | [2...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Assay buffer (50 mM Tris-HCl, 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.01% Triton-X-100, pH 8.0;ATX solution: ATX (human His-tagged) stock so... | US Patent US10882857 (2021) BindingDB Entry DOI: 10.7270/Q2SQ93GX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM477060 (US10882857, Example 3.01 | US11673888, Example 3.0...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2NV9P52 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM477049 (US10882857, Example 1.01 | US11673888, Example 1.0...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2NV9P52 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM477042 (US10882857, Example 1 | US11673888, Example 1 | [2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2NV9P52 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511559 (US11059794, Example 6.19 | tert-butyl 4-(2-fluoro-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511557 (US11059794, Example 6.17 | tert-butyl 4-[2-(2-fluo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511548 (US11059794, Example 6.10 | tert-butyl 3-(2-fluoro-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-1 (Homo sapiens (Human)) | BDBM511520 (US11059794, Example 2.00 | US11059794, Example 2.0...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K51 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM442711 (US10647719, Example 1.22 | [6-chloro-3-(2,2-) | UniProtKB/SwissProt GoogleScholar AffyNet | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. US Patent | Assay Description Human carbonic anhydrase II (hCA-II) inhibition was measured by an absorbance method using 4-nitrophenyl acetate (4-NPA) as its substrate. 4-NPA can ... | US Patent US10647719 (2020) BindingDB Entry DOI: 10.7270/Q2V98C4V | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 403 total ) | Next | Last >> |